Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmic, vitamins, minerals, dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, and analgesics; and anti-oxidants, balanced energy and protein drinks, and vitamins and nutraceuticals, as well as various active pharmaceutical ingredients. It provides its products under the Zifi, Zefu, Zocon, Amodep-AT, Zathrin, Mycoderm, Zoxan, Cotaryl, Pyrimon DF, Zipod, Vitcofol, Ziglim, Ziglim Plus 2, Electral, and Enerzal brand names. The company was founded in 1936 and is headquartered in Mumbai, India.

Revenue projections:

Revenue projections for FDC
Revenue projections for FDC



Financial Ratios:

currentRatio 0.00000
forwardPE 0.00000
debtToEquity 0.85200
earningsGrowth -0.23700
revenueGrowth 0.00100
grossMargins 0.66139
operatingMargins 0.08069
trailingEps 13.32000
forwardEps 23.30000

FDC Limited's low earnings and revenue growth point to a possible reduction in profits. This trend suggests that the company may face difficulties in maintaining its profitability and could be a cause for concern among investors.
FDC Limited's negative gross and operating margins indicate that the company is not generating profit from either production or day-to-day operations. This could suggest cost overruns or declining revenue, impacting its financial stability.
FDC's forward EPS is greater than its trailing EPS, indicating that the company is expected to deliver higher profitability this year. This suggests that FDC is projected to improve its earnings, reflecting positive growth compared to last year's financial performance.

Recommendation changes over time:

Recommendations trend for FDC
Recommendations trend for FDC


Analysts' recent buy bias toward FDC suggests the stock is gaining favor as a strong investment choice. This optimism could drive more investors to see FDC as a smart place to invest, further bolstering confidence in the company's long-term growth and potential returns.